Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
February 02, 2024 09:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
January 10, 2024 17:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third quarter earnings release on Thursday,...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
December 22, 2023 09:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
November 24, 2023 08:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate...
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
November 02, 2023 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $286.3 Million in Q2, Ahead of OutlookDiluted EPS of $1.07 in Q2, Up Over 5% Versus Prior YearReduced Leverage Ratio to 3.0x at Quarter EndReaffirming Full-Year Fiscal 2024 Revenue,...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
October 05, 2023 16:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday,...
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
September 05, 2023 17:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday,...
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
August 03, 2023 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $279.3 Million in Q1, up 0.8% versus Prior Year and up 1.8% excluding Foreign CurrencyReduced Leverage Ratio to 3.2x at Quarter End and Completed $25 Million Share Repurchase...
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results
July 11, 2023 08:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 first quarter earnings release on Thursday, August...
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
July 06, 2023 16:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 06, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced the release of its inaugural Environmental, Social, and...